Is It Time To Reassess Alignment Healthcare (ALHC) After Its Recent Share Price Swings

Simply Wall St.

Mar 03

If you are wondering whether Alignment Healthcare is attractively priced at its current level, this article will walk through how the market might be valuing the stock today and what that could mean ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2616992903"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2616992903\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2616992903?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","is_english":true,"pubTime":"2026-03-03 10:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616992903","market":"nz","top_or_hot":-1,"title":"Is It Time To Reassess Alignment Healthcare (ALHC) After Its Recent Share Price Swings","media":"Simply Wall St.","content":"<div>\n<p>If you are wondering whether Alignment Healthcare is attractively priced at its current level, this article will walk through how the market might be valuing the stock today and what that could mean ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/is-it-time-to-reassess-alignment-healthcare-alhc-after-its-r\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Time To Reassess Alignment Healthcare (ALHC) After Its Recent Share Price Swings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Time To Reassess Alignment Healthcare (ALHC) After Its Recent Share Price Swings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-03 10:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/is-it-time-to-reassess-alignment-healthcare-alhc-after-its-r><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you are wondering whether Alignment Healthcare is attractively priced at its current level, this article will walk through how the market might be valuing the stock today and what that could mean ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/is-it-time-to-reassess-alignment-healthcare-alhc-after-its-r\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XBI","symbol_name":"SPDR S&P Biotech ETF","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/is-it-time-to-reassess-alignment-healthcare-alhc-after-its-r","article_id":"2616992903","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/is-it-time-to-reassess-alignment-healthcare-alhc-after-its-r","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2616992903","pubTimestamp":1772504432,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you are wondering whether Alignment Healthcare is attractively priced at its current level, this article will walk through how the market might be valuing the stock today and what that could mean for you.\nThe share price closed at US$19.65 recently, with returns of a 1.3% decline over the last week, a 12.8% decline over the last month, a 2.8% decline year to date, and a 26.6% gain over the past year, as well as a very large gain over three years.\nThese moves have come alongside ongoing...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"XBI":"SPDR S&P Biotech ETF","BK4585":"ETF&股票定投概念","BK4154":"管理型保健护理","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK4581":"高盛持仓","LABU":"三倍做多标普生物-Direxion","ALHC":"Alignment Healthcare, Inc.","BK4588":"碎股","XLV":"健康照护类股ETF-SPDR","BK4539":"次新股"},"translate_title":"Alignment Healthcare(ALHC)最近股价波动后，是时候重新评估其股价了吗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALHC":1.5,"DCF":1,"XBI":0.6,"XLV":1.5,"LABU":0.6},"content_text":"If you are wondering whether Alignment Healthcare is attractively priced at its current level, this article will walk through how the market might be valuing the stock today and what that could mean for you. The share price closed at US$19.65 recently, with returns of a 1.3% decline over the last week, a 12.8% decline over the last month, a 2.8% decline year to date, and a 26.6% gain over the past year, as well as a very large gain over three years. These moves have come alongside ongoing attention on Alignment Healthcare’s position within the US healthcare sector and how investors view companies focused on senior care and Medicare Advantage plans. Recent discussions in the market have focused on how such business models handle costs, member growth, and regulatory changes, which can all influence sentiment and pricing. Right now, Alignment Healthcare scores 5 out of 6 on our valuation checks, giving it a value score of 5/6. Next we will look at how different valuation methods line up before finishing with a more complete way to think about what that score really means.  Alignment Healthcare delivered 26.6% returns over the last year. See how this stacks up to the rest of the Healthcare industry. AdvertisementApproach 1: Alignment Healthcare Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back to today’s value, to estimate what the business might be worth right now. For Alignment Healthcare, the model used here is a 2 Stage Free Cash Flow to Equity approach. The company’s latest twelve month free cash flow is reported at $91.39 million. Based on analyst estimates and then extended projections by Simply Wall St, free cash flow is forecast to reach $559.94 million in 2035, with interim projections such as $150.15 million in 2026, $198.55 million in 2027, and $271.05 million in 2028, all in $ and expressed in millions. After discounting these projected cash flows back to today, the model arrives at an estimated intrinsic value of $52.67 per share. Compared with the recent share price of $19.65, this DCF output indicates that, under these assumptions, the stock is valued 62.7% below the model’s estimate of intrinsic value. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests Alignment Healthcare is undervalued by 62.7%. Track this in your watchlist or portfolio, or discover 45 more high quality undervalued stocks. ALHC Discounted Cash Flow as at Mar 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Alignment Healthcare. Approach 2: Alignment Healthcare Price vs Sales For companies where earnings are limited or volatile, the P/S ratio is often more useful than P/E, because it compares what investors are paying for each dollar of revenue rather than each dollar of profit. Growth expectations and risk still matter, since faster revenue growth or lower perceived risk can support a higher P/S multiple, while slower growth or higher risk usually calls for a lower one. Alignment Healthcare currently trades on a P/S ratio of 1.02x. That sits below the Healthcare industry average P/S of 1.26x and below the peer group average of 1.66x. Simply Wall St also calculates a Fair Ratio of 0.99x for Alignment Healthcare, which is the P/S multiple it might expect based on factors such as earnings growth, profit margin, industry, market cap, and company specific risks. This Fair Ratio can be more useful than a simple industry or peer comparison, because it adjusts for the company’s own characteristics rather than assuming all Healthcare stocks should trade on the same multiple. With the current P/S at 1.02x compared with a Fair Ratio of 0.99x, Alignment Healthcare screens as slightly above that estimate, but the gap is small. Result: ABOUT RIGHT NasdaqGS:ALHC P/S Ratio as at Mar 2026 P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies. Upgrade Your Decision Making: Choose your Alignment Healthcare Narrative Earlier we mentioned that there is an even better way to understand valuation. On Simply Wall St you can use Narratives, which are simple stories that you and other investors attach to the numbers, connecting your view on Alignment Healthcare’s future revenue, earnings and margins to a forecast and then to a fair value that you can compare with the current share price on the Community page used by millions of investors. For Alignment Healthcare, one Narrative might lean toward the higher fair value of about US$30.0 with assumptions closer to the more optimistic revenue growth and margin improvement. Another might sit nearer US$18.0 with more cautious expectations. Because Narratives update automatically when new earnings, guidance or news is added, you can see in real time how different views translate into different fair values and decide for yourself whether the current price looks high, low or broadly in line with the story you find most reasonable. For Alignment Healthcare, here are previews of two leading Alignment Healthcare Narratives: 🐂 Alignment Healthcare Bull Case Fair value in this bullish Narrative: US$30.00 per share Implied discount to this fair value at the recent US$19.65 price: around 35% Assumed annual revenue growth: about 36.75%  Analysts in this camp focus on strong AEP sales, high member retention and an aging US senior population as drivers they expect to support higher revenue and earnings visibility over time. They see Alignment Healthcare's holistic, data driven care model and low SG&A ratio as a way to scale while improving margins, helped by automation and AI initiatives. This view leans on the idea that, if those assumptions hold, a higher P/E multiple in future could be supported by revenue growth, margin expansion and longer term earnings power.  🐻 Alignment Healthcare Bear Case Fair value in this bearish Narrative: US$18.00 per share Implied premium to this fair value at the recent US$19.65 price: around 9% Assumed annual revenue growth: about 28.14%  This Narrative highlights risks from Medicare Advantage reimbursement changes, regulatory scrutiny and sector wide underwriting pressure that could affect future revenue and margins. It also points to thin margins, negative free cash flow and competition from much larger peers as reasons the shares might not justify a higher valuation if medical costs or member growth do not meet expectations. Here, the concern is that even with revenue growth, earnings and valuation could be constrained if margin recovery is slower or more uneven than analysts in this group are assuming.  Taken together, these Narratives provide a structured bullish and bearish range around Alignment Healthcare's current price. If you want to see how other investors are framing the same numbers, and build your own version of the story, you can start from these two templates and adjust the inputs that matter most to you. Do you think there's more to the story for Alignment Healthcare? Head over to our Community to see what others are saying! NasdaqGS:ALHC 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}